We are live on ! Find out more
KB

Kimelman & Baird Portfolio holdings

AUM $1.22B
1-Year Est. Return 11.47%
This Fund
S&P 500
This Quarter Est. Return
+2.22%
1 Year Est. Return
+11.47%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$660M
AUM Growth
+$3.27M
Cap. Flow
-$5.55M
Cap. Flow %
-0.84%
Top 10 Hldgs %
37.72%
Holding
128
New
6
Increased
27
Reduced
22
Closed
7

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$14.7M
2
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$5.15M
3
COP icon
ConocoPhillips
COP
+$4.54M
4
FTI icon
TechnipFMC
FTI
+$455K
5
MRK icon
Merck
MRK
+$354K

Top Sells

Rank Stock Value
1
CPRT icon
Copart
CPRT
+$16.6M
2
CMD
Cantel Medical Corporation
CMD
+$9.35M
3
LLY icon
Eli Lilly
LLY
+$2.25M
4
MJN
Mead Johnson Nutrition Company
MJN
+$1.34M
5
BMY icon
Bristol-Myers Squibb
BMY
+$490K

Sector Composition

Rank Sector Weight
1 Industrials 18.86%
2 Financials 14.21%
3 Healthcare 12.56%
4 Consumer Discretionary 12.5%
5 Communication Services 11.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HDB icon
101
HDFC Bank
HDB
$119B
$261K 0.04%
12,000
– –
IBM icon
102
IBM
IBM
$202B
$243K 0.04%
1,653
-205
-11% -$30.9K
SPY icon
103
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$224K 0.03%
925
– –
SO icon
104
Southern Company
SO
$110B
$221K 0.03%
4,614
– –
LOGI icon
105
Logitech
LOGI
$15.2B
$220K 0.03%
+6,000
New +$208K
GD icon
106
General Dynamics
GD
$105B
$218K 0.03%
1,102
-200
-15% -$39.2K
VIAB
107
DELISTED
Viacom Inc. Class B
VIAB
$218K 0.03%
6,500
– –
EPD icon
108
Enterprise Products Partners
EPD
$83.8B
$217K 0.03%
8,000
– –
NVO
109
Novo Nordisk
NVO
$216B
$214K 0.03%
+10,000
New +$202K
DUK icon
110
Duke Energy
DUK
$102B
$213K 0.03%
2,543
– –
CSX icon
111
CSX Corp
CSX
$98.6B
$208K 0.03%
+11,424
New +$196K
MSFT icon
112
Microsoft
MSFT
$2.84T
$201K 0.03%
+2,918
New +$200K
ORLY icon
113
O'Reilly Automotive
ORLY
$72.4B
– –
-15,000
Closed -$270K
PFE icon
114
Pfizer
PFE
$140B
– –
-6,253
Closed -$203K
VZ icon
115
Verizon
VZ
$194B
– –
-4,154
Closed -$203K
VMW
116
DELISTED
VMware, Inc
VMW
– –
-2,200
Closed -$203K
DISCK
117
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
– –
-7,500
Closed -$212K
MJN
118
DELISTED
Mead Johnson Nutrition Company
MJN
– –
-15,010
Closed -$1.34M
SE
119
DELISTED
Spectra Energy Corp Wi
SE
– –
-5,000
Closed -$203K
1 2 3 4
5

Similar funds

DPI
Diversified Portfolios Inc Bloomfield Hills, Michigan $1.22B AUM 11.83% 1-Year Est. Return
NPIC
Neumeier Poma Investment Counsel Carmel, California $1.21B AUM 70.48% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return
AG
Atairos Group Bryn Mawr, Pennsylvania $1.22B AUM 38.2% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.22B AUM 7.54% 1-Year Est. Return
LWIC
Leith Wheeler Investment Counsel Vancouver, British Columbia, Canada $1.21B AUM 12.04% 1-Year Est. Return

Kimelman & Baird's Q2 2017 Portfolio in Review

As of Q2 2017, Kimelman & Baird held 128 positions worth $660M, up 0.5% from $657M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Kimelman & Baird's Q2 2017 filing shows 6 new, 27 increased, 22 reduced and 7 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M. The largest sale was Copart, an estimated $16.6M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.

  • Kimelman & Baird's largest Q2 2017 buy was State Street SPDR S&P Biotech ETF: 72,640 shares worth $5.61M.
  • Kimelman & Baird added most to Costco in Q2 2017, an estimated $14.7M increase.
  • Kimelman & Baird's biggest Q2 2017 reduction was Copart, cutting an estimated $16.6M.
  • Kimelman & Baird fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $1.34M.
  • Kimelman & Baird's ten largest holdings make up 38% of its $660M portfolio in Q2 2017.
  • Kimelman & Baird opened 6 new positions and closed 7 in Q2 2017.
  • Kimelman & Baird's portfolio value rose 0.5% quarter-over-quarter to $660M.

Based on Kimelman & Baird's 13F filing for Q2 2017, filed 22 Aug 2017.